CPRX - Catalyst Pharmaceuticals Inc. (CPRX) CEO Patrick McEnany on Q4 2020 Results - Earnings Call Transcript
Start Time: 08:30 End Time: 09:18 Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2020 Earnings Conference Call March 16, 2021, 08:30 AM ET Company Participants Patrick McEnany - Co-Founder, Chairman and CEO Alicia Grande - VP, CFO and Treasurer Steven Miller - COO and Chief Scientific Officer Jeff Del Carmen - Chief Commercial Officer Conference Call Participants Joe Catanzaro - Piper Sandler Charles Duncan - Cantor Fitzgerald Les Sulewski - Truist Securities Scott Henry - ROTH Capital Presentation Operator Greetings, and welcome to the Catalyst Pharmaceuticals' Fourth Quarter and Fiscal Year 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Ali Grande, Chief Financial Officer. Thank you. Please go ahead. Alicia Grande Good morning everyone and thank you
For further details see:
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q4 2020 Results - Earnings Call Transcript